Animal Core Facility
Animal Core Facility
批准号:
10666695
负责人:
John Curlee Wilkinson
金额:
$59.72万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-03-01 至 2027-06-30
关键词:
AchievementAddressAdvisory CommitteesAnimal Cancer ModelAnimal ExperimentationAnimal ExperimentsAnimal HousingAnimal ModelAnimalsApoptosisAreaBiological ModelsBiomedical ResearchBreedingCancer EtiologyCarcinogenesis MechanismCell CommunicationCenters of Research ExcellenceCessation of lifeClinicalClinical ManagementCollaborationsCommunitiesComplementComplexCore FacilityDevelopmentDiagnosisDiagnosticDiseaseEarly DiagnosisEarly treatmentElementsEnsureExperimental DesignsExtramural ActivitiesFacultyFaculty RecruitmentFluorouracilFosteringGenetic EngineeringGenetically Engineered MouseGoalsHistocytochemistryHistologyHousingIACUCImmunocompromised HostImmunohistochemistryIndividualInstitutionInvadedKPC modelKRASG12DLeucovorinLongevityMaintenanceMalignant NeoplasmsMalignant neoplasm of pancreasMentorsMethodsMissionModelingMouse StrainsMusNational Cancer InstituteNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of General Medical SciencesNeoplasm MetastasisPancreatic Ductal AdenocarcinomaPatientsPhasePilot ProjectsPlayPostdoctoral FellowProductivityRegimenRegulationResearchResearch InfrastructureResearch PersonnelResourcesRoleSamplingScientistSenior ScientistServicesSiteSolidSurvival RateTestingTherapeuticTissuesToxic effectTrainingUnited StatesUnited States National Institutes of Healthanimal careanticancer researchbiobankcancer diagnosiscancer therapycareercell typechemotherapeutic agentefficacy studyfluorescence imaginggemcitabinegraduate studentimaging approachimaging modalityimplantationimprovedin vivoirinotecanmodel developmentnovelnovel therapeutic interventionnovel therapeuticsoxaliplatinpatient derived xenograft modelprogramsprotocol developmentstandard of caresubcutaneoustranslational studytreatment responsetreatment strategytumorworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract (Animal Core Facility)
Animal models play a vital role in the establishment and refinement of improved therapies for various
cancers, including pancreatic ductal adenocarcinoma (PDAC). Thus, when the NDSU Center for Diagnostic
and Therapeutic Strategies in Pancreatic Cancer was established, a key component included was the Animal
Research Core Facility. During Phase I of this project, the Animal Core has made significant contributions to
the COBRE project's mission and the overall NDSU research community. A breeding colony of nod-SCID-
gamma (NSG™) mice was founded and used in multiple grafting studies, including subcutaneous, orthotopic,
and patient-derived xenograft implantations. The Core also established a colony of genetically engineered
LSL-KrasG12D/+; LSL-Trp53R172H/+; Pdx-1-Cre (KPC) mice to complement these NSG™ studies. These
achievements allowed the Animal Core to complete our original goals of enhancing basic and translational
studies devoted to detecting and treating pancreatic cancer and strengthening biomedical research at NDSU.
For Phase II, the Animal Core aims are 1) to support the scientific and animal needs of individual Junior
Investigators, Pilot Project Investigators, new and existing faculty, postdoctoral fellows, and graduate students
associated with the CDTSPC; and 2) to increase the sustainability of the Animal Core Research platform.
These aims will be achieved by establishing new colonies of genetically engineered models (including KC-
smad4 and KC-Tgfbr2 strains), establishing a tissue biobank for archival maintenance of PDAC and other
cancer samples, and expanding services to include on-site histology analysis and advanced imaging
modalities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金